Functional role of estrogen metabolism in target cells: Review and perspectives

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 1-27

  Zhu, Bao Ting ^a   Conney, Allan H ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR;

BRAIN; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; HYDROXYLATION; MAMMARY GLAND; PRIORITY JOURNAL; REVIEW; TARGET ORGAN; UTERUS;

ANDROGENS; ANIMALS; BRAIN; BREAST; ESTRADIOL; ESTROGENS; ESTROGENS, CATECHOL; ESTRONE; FEMALE; HUMANS; HYDROXYLATION; RECEPTORS, ESTROGEN; UTERUS;

EID: 0031848636     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.1     Document Type: Review

References (496)

1. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.R. and Chambon, P. (1987) Functional domains of the human estrogen receptor. Cell, 51, 941-951.
2. Evans, R.M. (1988) The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
3. Weisz, A., Cicatiello, L., Persicot, E., Scalona, M. and Bresciani, F. (1990) Estrogen stimulates transcription of c-jun protooncogene. Mol. Endocrinol., 4, 1041-1050.
4. Parker, M.G. (ed.) (1991) Nuclear Hormone Receptors. Academic Press, London.
5. Martin, L., Finn, C.A. and Trinder, G. (1973) Hypertrophy and hyperplasia in the mouse uterus after estrogen treatment: an autoradiographic study. J. Endocrinol., 56, 133-141.
6. Quarmby, V.E. and Korach, K.S. (1984) Influence of 17β-estradiol on the pattern of cell division in the uterus. Endocrinology, 114, 694-702.
7. Silver, M. (1953) A quantitative analysis of the role of oestrogen in mammary development in the rat. J. Endocrinol., 10, 17-34.
8. Banerjee, M.R. (1976) Responses of mammary cells to hormones. Int. Rev. Cytol., 4, 1-97.
9. Holland, M.B. and Roy, D. (1995) Estrogen-induced cell proliferation and differentiation in the mammary gland of the female Noble rat. Carcinogenesis, 16, 1955-1961.
10. Nandi, S., Guzma, R.C. and Yang, J. (1995) Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl Acad. Sci. USA, 92, 3650-3657.
11. Li, J.J. and Li, S.A. (1996) The effects of hormones on tumor induction. In Arcos, J.G., Argus, M.F. and Woo, Y.T. (eds) Chemical Induction of Cancer. Birkhauser, Boston, pp. 396-449.
12. Ziel, H.K. and Finkle, W.D. (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med., 293, 1167-1170.
13. Mack, T.M., Pike, M.C., Henderson, B.E., Pfeffer, R.I., Gerkins, V.R., Arthur, M. and Brown, S.E. (1976) Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med., 294, 1262-1267.
14. McDonald, T.W., Annegers, J.F., O'Fallow, W.M., Dockerty, M.B., Malkasian, G.D., Jr and Karland, L.T. (1977) Exogenous estrogens and endometrial carcinoma: case control and incidence study. Am. J. Obstet. Gynecol., 127, 572-580.
15. Jick, H., Walker, A.M., Watkins, R.N., D'ewart, D.C., Hunter, J.R., Danford, A., Madsen, S., Dinan, B.J. and Rothman, K.J. (1980) Replacement estrogens and breast cancer. Am. J. Epidemiol., 112, 586-594.
16. Pike, M.C., Spicer, D.V., Dahmoush, L. and Press, M.F. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15, 17-35.
17. Feigelson, H.S. and Henderson, B.E. (1996) Estrogens and breast cancer. Carcinogenesis, 17, 2279-2284.
18. Grady, D. and Ernster, V.L. (1996) Endometrial cancer. In Schottenfeld, D. and Fraumeni, J.F., Jr (eds) Cancer Epidemiology and Prevention, 2nd edn. Oxford University Press, Oxford, pp. 1058-1089.
19. Martucci, C.P. and Fishman, J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. Ther., 57, 237-257.
20. Musey, P.I., Kright, K., Preedy, J.R.K. and Collins, D.C. (1997) Formation and metabolism of steroid conjugates: effect of conjugation on excretion and tissue distribution. In Hobkirk, R. (ed.) Steroid Biochemistry, Vol. II. CRC Press, Boca Raton, FL, pp. 81-132.
21. Ritter, J.K., Sheen, Y.Y. and Owens, I.S. (1990) Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates. J. Biol. Chem., 265, 7900-7906.
22. Zhu, B.T., Suchar, L.S., Huang, M.-T. and Conney, A.H. (1996) Similarities and differences in the glucuronidation of estradiol and estrone by UDP-glucuronosyltransferase in liver microsomes from male and female rats. Biochem. Pharmacol., 51, 1195-1202.
23. Brooks, S.C. and Horn, L. (1971) Hepatic sulfonation of estrogen metabolites. Biochim. Biophys. Acta, 231, 233-241.
24. 19 steroids. In Hobkirk, R. (ed.) Steroid Biochemistry, vol I. CRC Press, Boca Raton, FL, pp. 111-145.
25. Hobbirk, R. (1985) Steroid sulfotransferases and steroid sulfate sulfatases: Characteristics and biological roles. Can. J. Biochem. Cell Biol., 63, 1127-1144.
26. Watanabe, K., Takanashi, K. and Yoshizawa, I. (1988) Determination of estradiol-17-sulfate in human urine by a direct radioimmunoassay: urinary levels throughout the menstrual cycle. Steroids, 52, 123-136.
27. Hernandez, J.S., Watson, R.W.G., Wood, T.C. and Weinshilboum, R.M. (1992) Sulfation of estrone and 17β-estradiol in human liver. Catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase. Drug Metab. Dispos., 20, 413-422.
28. Axelrod, J. and Tomchick, R. (1958) Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem., 233, 702-705.
29. Guldberg, H.C. and Marsden, C.A. (1975) Catechol-O-methyltransferase: pharmacological aspects and physiological role. Pharmacol. Rev., 27, 135-206.
30. Ball, P. and Knuppen, R. (1980) Catecholoestrogens (2- and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol., 232, 1-127.
31. Fishman, J. and Norton, B. (1975) Catechol estrogen formation in the central nervous system of the rat. Endocrinology, 96, 1054-1059.
32. Ball, P., Knuppen, R., Haupt, M. and Breuer, H. (1972) Interactions between estrogens and catechol amines. III. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the catechol O-methyltransferase of human liver. J. Clin. Endocrinol. Metab., 34, 736-746.
33. Breuer, H. and Köster, G. (1974) Interaction between estrogens and neurotransmitters at the hypophysial-hypothalamic level. J. Steroid Biochem., 5, 961-967.
34. Ghraf, R. and Hiemke, C.H. (1983) Interaction of catechol estrogens with catecholamine synthesis and metabolism. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York, pp. 177-187.
35. Gurpide, E. (1978) Enzymatic modulation of hormonal action at the target tissue. J. Toxicol. Environ. Hlth, 4, 249-268.
36. Vermeulen, A. (1986) Human mammary cancer as a site of sex steroid metabolism. Cancer Surveys, 5, 587-595.
37. Santen, R.J. (1986) Determinants of tissue oestradiol levels in human breast cancer. Cancer Surveys, 5, 598-616.
38. Weisz, J. (1991) Metabolism of estrogens by target cells: Diversification and amplification of hormone action and the catechol estrogen hypothesis. In Hochberg R.B. and Naftolin, F. (eds), New Biology of Steroid Hormones. Raven Press, New York, pp. 101-112
39. Roy, A.K. (1992) Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proc. Soc. Exp. Biol. Med., 199, 265-272.
40. Weisz, J. (1994) Biogenesis of catecholestrogens: metabolic activation of estrogens by Phase I enzymes. Polycyclic Aromatic Comp., 6, 241-251.
41. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S. and Gustafsson, J.-Å. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA, 93, 5925-5930.
42. Karas, R.H., Baur, W.E., van Eickles, M. and Mendelsohn, M.E. (1995) Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Lett., 377, 103-108.
43. Hirata, S., Koh, T., Yamada-Mouri, N. and Kato, J. (1996) The novel untranslated first exon 'exon ON′ of the rat estrogen receptor gene. Biochem. Biophys. Res. Commun., 225, 849-854.
44. Mosselman, S., Polman, J. and Dijkema, R. (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392, 49-53.
45. Inoue, S., Hoshino, S., Miyoshi, H., Akishita, M., Hosoi, T., Orimo, H. and Ouchi, Y. (1996) Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 219, 766-772.
46. Suchar, L.A., Chang, R.L., Rosen, R.T., Lech, J. and Conney, A.H. (1995) High performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. J. Pharmacol. Exp. Ther., 272, 197-206.
47. 14C]estrone in hamster and rat hepatic and renal microsomes: species-, sex- and age-specific differences. J. Steroid Biochem. Mol. Biol., 42, 389-397.
48. Zhu, B.T., Lech, J., Rosen, R.T. and Conney, A.H. (1997) Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice. Cancer Res., 57, 2419-2427.
49. Ball, P., Knuppen, R., Haupt, M. and Breuer, H. (1972) Interactions between estrogens and catechol amines. III. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the catechol-O-methyltransferase of human liver. J. Clin. Endocrinol., 34, 736-746.
50. Fishman, J. and Dixon, D. (1967) 2-Hydroxylation of estradiol by human placental microsomes. Biochemistry, 6, 1683-1687.
51. Paul, S.M., Axelrod, J. and Diliberto, E.J. (1977) Catechol estrogen-forming enzyme of brain: demonstration of a cytochrome P450 monooxygenase. Endocrinology, 101, 1604-1610.
52. Ball, P., Haupt, M. and Knuppen, R. (1978) Comparative studies on the metabolism of oestriol in the brain, the pituitary and the liver of the rat. Acta Endocrinol., 87, 1-11.
53. Ball, P. and Knuppen, R. (1978) Formation of 2- and 4-hydroxyestrogens by brain, pituitary, and liver of the human fetus. J. Clin. Endocrinol. Metab., 47, 732-737.
54. Fishman, J., Norton, B.I. and Krey, L. (1980) 2-Hydroxylation of estrogens in the brain participates in the initiation of the preovulatory LH surge in the rat. Biochem. Biophys. Res. Commun., 93, 471-477.
55. 3H]estradiol by rabbit hypothalami in vitro. Endocrinology, 109, 1902-1911.
56. Hersey, R.M., Williams, K.I.H. and Weisz, J. (1981) Catechol estrogen formation by brain tissue: characterization of a direct product isolation assay for estrogen-2- and 4-hydroxyestradiol formation by rabbit hypothalamus. Endocrinology, 109, 1912-1920.
57. Hersey, R.M. and Weisz, J. (1983) A product isolation assay for estrogen-2/4-hydroxylase activity. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York, pp. 37-48.
58. Maschler, I., Ball, P., Bayerköhler, G., Gaues, J. and Knuppen, R. (1983) Identification of 6α- and 7α-hydroxyestrone as major metabolites of estrone and estradiol in porcine uterus. Steroids, 41, 597-607.
59. Jellinck, P.H., Hahn, E.F., Norton, B.I. and Fishman, J. (1985) Catechol estrogen formation and metabolism in brain tissue: comparison of tritium release from different portions of ring A of the steroids. Endocrinology, 115, 1850-1856.
60. Li, S.A., Klicka, J.K. and Li, J.J. (1985) Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res., 45, 181-185.
61. Mondschein, J.S., Hersey, R.M., Dey, S.K., Davis, S.K. and Weisz, J. (1985) Catecholestrogen formation by the pig blastocyst during the preimplantation period: biochemical characterization of estrogen-2/4-hydroxylase and correlation with aromatase activity. Endocrinology, 117, 2339-2346.
62. Hammond, J.M., Hersey, R.M., Walega, M.A. and Weisz, J. (1986) Catecholestrogen production by porcine ovarian cells. Endocrinology, 118, 2292-2299.
63. Bui, Q. and Weisz, J. (1988) Identification of microsomal, organic hydroperoxide-dependent catechol estrogen formation: Comparison with NADPH-dependent mechanism. Pharmacology, 36, 356-364.
64. Bunyagidj, C. and McLachlan, J.A. (1988) Catechol estrogen formation in mouse uterus. J. Steroid Biochem., 31, 795-801.
65. Chakraborty, C., Davis, D.L. and Dey, S.K. (1988) Characteristics of estrogen-2/4-hydroxylase in pig blastocysts. Inhibition by steroidal and non-steroidal agents. J. Steroid Biochem., 31, 231-235.
66. Bui, Q.D. and Weisz, J. (1988) Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. Endocrinology, 124, 1085-1087.
67. Chakraborty, C., Dey, S.K. and Davis, D.L. (1989) Pattern and tissue distribution of catechol estrogen forming activity by pig conceptuses during the peri-implantation period. J. Anim. Sci., 67, 991-998.
68. Telang, N.T., Bradlow, H.L., Kurihara, H. and Osborne, M.P. (1989) In vitro biotransformation of estradiol by explant cultures of murine mammary tissues. Breast Cancer Res. Treat., 13, 173-181.
69. Brueggemeier, R.W., Katlic, N.E, Palmer, C.W., Jr and Stevens, J.M. (1989) Catechol estrogen formation in MCF-7 cell culture and effects of bromoestrogen inhibitors. Mol. Cell. Endocrinol., 64, 161-167.
70. Spink, D.C., Lincoln, D.W., Dickerman, H.W. and Gierthy, J.F. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells. Proc. Natl Acad. Sci. USA, 87, 6917-6921.
71. Brueggemeier, R.W., Tseng, K., Katlic, N.E., Beleh, M.A. and Lin, Y.C. (1990) Estrogen metabolism in primary kidney cell cultures from Syrian hamsters. J. Steroid Biochem., 36, 325-331.
72. Chakaborty, C., Huet-Hudson, Y.M. and Dey, S.K. (1990) Catecholoestrogen synthesis and metabolism in the rabbit uterus during the periimplantation period. J. Steroid Biocehm., 35, 39-46.
73. Paria, B.C., Chakraborty, C. and Dey, S.K. (1990) Catechol estrogen formation in the mouse uterus and its role in implantation. Mol. Cell. Endocrinol., 69, 25-32.
74. Telang, N.T., Axelrod, D.M., Wong, G.Y., Bradlow, H.L. and Osborne, M.P. (1991) Biotransformation of estradiol by explant culture of human mammary tissue. Steroids, 56, 37-43.
75. Spink, D.C., Eugster, H.P., Lincoln, D.W., Schuetz, J.D., Schuetz, E.G., Johnson, J.H., Kaminsky, L.S. and Gierthy, J.F. (1992) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293, 342-248.
76. Weisz, J., Bui, Q.D., Roy, D. and Liehr, J.G. (1993) Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology, 131, 655-661.
77. Zhu, B.T., Roy, D. and Liehr, J.G. (1993) The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology, 132, 577-583.
78. Adamski, J., Hohls, E. and Jungblut, P.W. (1994) Characterization of estrone hydroxylase activities in porcine endometrial cells. Exp. Clin. Endocrinol., 102, 388-393.
79. Zhu, B.T., Bui, Q.D., Weisz, J. and Liehr, J.G. (1994) Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis. Endocrinology, 135, 1772-1779.
80. Liehr, J.G., Ricci, M.J., Jefcoate, C.R., Hannigan, E.V., Hokanson, J.A. and Zhu, B.T. (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc. Natl Acad. Sci. USA, 92, 9220-9224.
81. Liehr, J.G. and Ricci, M.J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl Acad. Sci. USA, 93, 3294-3296.
82. Hammond, D.K., Zhu, B.T., Wang, M.Y., Ricci, M.J. and Liehr, J.G. (1997) Cytochrome P450 metabolism of estradiol in hamster liver and kidney. Toxicol. Appl. Pharmacol., 145, 54-60.
83. Hellmold, H., Lamb, J.G., Wyss, A., Gustafsson, J.-Å. and Warner, M. (1995) Developmental and endocrine regulation of P-450 isoforms in rat breast. Mol. Pharmacol., 48, 630-638.
84. Smith, G., Harrison, D.J., East, N., Rae, F., Wolf, H. and Wolf, C.R. (1993) Regulation of cytochrome P450 gene expression in human and breast tumor xenografts. Br. J. Cancer, 68, 57-63.
85. Spink, D.C., Hayes, C.L., Young, N.R., Christou, M., Sutter, T.R., Jefcoate, C.R. and Gierthy, J.F. (1994) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol., 51, 251-258.
86. Hayes, C.L., Spink, D.C., Spink, B.C., Cao, J.Q., Walker, N.J. and Sutter, T.R. (1996) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl Acad. Sci. USA, 93, 9776-9781.
87. Kirkman, H. (1959) Estrogen-induced tumors of the kidney in Syrian hamster. III. Growth characteristics in the Syrian hamster. NCI Monogr., 1, 1-57.
88. Li, J.J. and Li, S.A. (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46, 1858-1863.
89. Liehr, J.G., Fang, W.F., Sirbasku, D.A. and Ulubelen, A.A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid. Biochem., 24, 353-356.
90. Seegers, J.C., Aveling, M.-L., van Aswegen, C.H., Cross, M., Koch, F. and Joubert, W.S. (1989) The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and Hela cells. J. Steroid Biochem., 32, 797-809.
91. Lottering, M.-L., Haag, M. and Seegers, J.C. (1992) Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res., 52, 5926-5932.
92. D'Amato, R.J., Lin, C.M., Flynn, E., Folkman, J. and Hamel, E. (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl Acad. Sci. USA, 91, 3964-3968.
93. Fotsis, T., Zhang, Y., Pepper, M.S., Adlercreutz, H., Montesano, R., Nawroth, P.P. and Schwelgerer, L. (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature, 368, 237-239.
94. Hamel, E., Lin, C.M., Flynn, E. and D'Amato, R.J. (1996) Interaction of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and tubulin polymers. Biochemistry, 35, 1304-1310.
95. Klauber, N., Parangi, S., Flynn, E., Hamel, E. and D'Amato, R.J. (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res., 57, 81-86.
96. Kapitulnik, J, Gelboin, H.V., Guengerich, F.P. and Jacobowitz, D.M. (1987) Immunohistochemical localization of cytochrome P-450 in rat brain. Neuroscience, 20, 829-833.
97. Sugita, O., Miyairi, S., Sassa, S. and Kappas, A. (1987) Partial purification of cytochrome P-450 from rat brain and demonstration of estradiol hydroxylation. Biochem. Biophys. Res. Commun., 147, 1245-1250.
98. Warner, M., Köhler, C., Hansson, T. and Gustafsson, J.-Å. (1988) Regional distribution of cytochrome P450 in the rat brain: spectral quantitation and contribution of P450b, e and P450c, d. J. Neurochem., 50, 1057-1065.
99. Yamada, K., Harada, N., Tamaru, M. and Takagi, Y. (1993) Effects of changes in gonadal hormones on the amount of aromatase RNA in mouse brain diencephalon. Biochem. Biophys. Res. Commun., 195, 462-468.
100. Warner, M. and Gustafsson, J-Å. (1994) Effect of ethanol on cytochrome P450 in the rat brain. Proc. Natl Acad. Sci. USA, 91, 1019-1023.
101. Strömstedt, M., Warner, M. and Gustafsson, J.-Å. (1994) Cytochrome P450s of the 4A subfamily in the brain. J. Neurobiochem., 63, 671-676.
102. Ravindranath, V. and Boyd, M.R. (1995) Xenobiotic metabolism in brain. Drug Metab. Rev., 27, 419-448.
103. Wyss, A., Gustafsson, J.-Å. and Warner, M. (1995) Cytochrome P450s of the 2D subfamily in the rat brain. Mol. Pharmacol., 47, 1148-1155.
104. Ball, P., Emons, G., Klingebiel, T., Grühn, K.-M. and Knuppen, R. (1981) Effects of catecholestrogens on luteinizing hormone levels in long term ovariectomized adult rats. Endocrinology, 109, 1037-1039.
105. Ball, P., Franks, S., Naftolin, F. and Ruf, K.B. (1979) Influence of 2- and 4-hydroxyestrogens (catecholoestrogens) on the PMGS-induced premature ovulation in the immature rat. Acta Endocrinol., 25 (Suppl.), 102.
106. Emons, G. and Ball, P. (1982) Induction of ovulation in immature female rats by a single injection of 4-hydroxyoestradiol-dibenzoate. Acta Endocrinol., 100, 105-108.
107. Dehennin, L., Blacker, C., Reiffsteck, A, and Scholler, R. (1984) Estrogen 2-, 4-, 6-, or 16-hydroxylation by human follicles shown by gas chromatography-mass spectrometry associated with stable isotope dilution. J. Steroid Biochem., 20, 465-471.
108. Dannan, G.A., Porubek, D.J., Nelson, S.D., Waxman, D.J. and Guengerich, F.P. (1986) 17β-Estradiol 2- and 4-hydroxylation catalyzed by rat hepatic cytochrome P-450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement. Endocrinology, 118, 1952-1960.
109. Conney, A.H., Levin, W., Jacobson, M. and Kuntzman, R. (1973) Effects of drugs and environmental chemicals on steroid metabolism. Clin. Pharmacol. Ther., 14, 727-741.
110. Conney, A.H. (1986) The induction of microsomal cytochrome P-450 enzymes: The first Bernard B. Brodie lecture at Pennsylvania State University. Life Sci., 39, 2493-2518.
111. Suchar, L.A., Chang, R.L., Thomas, P.E., Rosen, R.T., Lech, J. and Conney, A.H. (1996) Effect of phenobarbital, dexamethasone and 3-methylcholanthrene administration on the metabolism of 17β-estradiol by liver microsomes from female Long-Evans rats. Endocrinology, 137, 663-676.
112. Kerlan, V., Dreano, Y., Bercovici, J.P., Beaune, P.H., Floch, H.H. and Berthou, F. (1992) Nature of cytochrome P450 involved in the 2-/ 4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol., 44, 1745-1756.
113. Ryan, D.E., Iida, S., Wood, A.W., Thomas, P.E., Lieber, C.S. and Levin, W. (1984) Characterization of three highly purified cytochromes P450 from hepatic microsomes of adult male rats. J. Biol. Chem., 259, 1239-1250.
114. C-M/F, a new constitutive form of microsomal cytochrome P450 in male and female rat liver with estrogen 2- and 16α-hydroxylase activity. Biochemistry, 27, 678-686.
115. Cheng, K.C. and Schenkman, J.B. (1984) Metabolism of progesterone and estradiol by microsomes and purified cytochrome P-450 RLM3 and RLM5. Drug Metab. Dispos., 12, 222-234.
116. Ishida, N., Tawaragi, Y., Inuzuka, C., Sugita, O., Kubota, I., Nakazoto, H., Noguchi, T. and Sassa, S. (1988) Four species of cDNAs for cytochrome P450 isozymes immunorelated to P450-M/F encode for members of P450 IID subfamily, increasing the number of members within the subfamily. Biochem. Biophys. Res. Commun., 156, 681-688.
117. Watanabe, K., Takanashi, K., Imaoka, S., Funae, Y., Kawano, S., Inoue, K., Kamataki, T., Takagi, H. and Yoshizawa, I. (1991) Comparison of cytochrome P-450 species which catalyze the hydroxylations of the aromatic ring of estradiol and estradiol 17-sulfate. J. Steroid Biochem. Biol., 38, 737-743.
118. Ball, S.E., Forrester, L.M., Wolf, C.R. and Back, D.J. (1990) Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17α-ethinyloestradiol. Biochem. J., 267, 221-226.
119. Shou, M., Korzekwa, K.R., Brooks, E.N., Krausz, K.W., Gonzalez, F.J. and Gelboin, H.V. (1997) Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis, 18, 207-214.
120. Guengerich, F.P. (1988) Oxidation of 17α-ethynylestradiol by human liver cytochrome P-450. Mol. Pharmacol., 33, 500-508.
121. Aoyama, T., Korzekwa, K., Gillette, J., Gelboin, H.V. and Gonzalez, F.J. (1990) Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s. Endocrinology, 126, 3101-3106.
122. Hoffman, A.R., Paul, S.M. and Axelrod, J. (1979) Catecholestrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res., 39, 4584-4587.
123. Osawa, Y., Higashiyama, T., Shimizu, Y. and Yarborough, C. (1993) Multiple functions of aromatase and the active site structure: aromatase is the placental estrogen 2-hydroxylase. J. Steroid Biochem. Mol. Biol., 44, 469-480.
124. de Waziers, I., Cugnenc, P.H., Yang, C.S., Leroux, J.P. and Beaune, P.H. (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther., 253, 387-394.
125. Jayyosi, Z., Cooper, K.O. and Thomas, P.E. (1992) Brain cytochrome P450 and testosterone metabolism by rat brain subcellular fractions: presence of cytochrome P450 3A immunoreactive protein in rat brain mitochondria. Arch. Biochem. Biophys., 298, 265-270.
126. Bui, Q.D., Weisz, J. and Wrighton, S.A. (1990) Hepatic catecholestrogen synthases: Differential effect of sex, inducers of cytochromes P-450 and antibody to glucocorticoid inducible cytochrome P-450 on NADPH-dependent estrogen-2-hydroxylase and on organic hydroperoxide-dependent estrogen-2/4-hydroxylase activity of rat hepatic microsomes. J. Steroid Biochem., 37, 285-293.
127. Levin, M., Weisz, J., Bui, Q.D. and Santen, R.J. (1987) Peroxidatic catecholestrogen production by human breast cancer tissue in vitro. J. Steroid Biochem., 28, 513-520.
128. Ball, P., Emons, G., Haupt, O., Hoppen, H.-O. and Knuppen, R. (1978) Radioimmunoassay of 2-hydroxy-estrone. Steroids, 31, 249-258.
129. Emons, G., Ball, P. and Knuppen, R. (1983) Radioimmunoassays of catecholestrogens. In Merriam, G.R. and Lipsett, M.B. (eds) Catecholestrogens. Raven Press, New York, pp. 71-81.
130. Emons, G., Merriam, R., Pfeiffer, D., Loriaux, D.L., Ball, P. and Knuppen, R. (1987) Metabolism of exogenous 4- and 2-hydroxyestradiol in human male. J. Steroid Biochem., 28, 499-504.
131. Fishman, J. and Martucci, C. (1979) Absence of measurable catechol estrogens in the rat brain - evidence for rapid turnover. J. Clin. Endocrinol. Metab., 49, 940-942.
132. Zhu, B.T. and Liehr, J.G. (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. J. Biol. Chem., 271, 1357-1363.
133. van Aswegen, C.H., Purdy, R.H. and Wittliff, J.L. (1989) Binding of 2-hydroxyestradiol and 4-hydroxyestrdiol to estrogen receptor human breast cancers. J. Steroid Biochem., 32, 485-492.
134. MacLusky, N.J., Barnea, E.R., Clark, C.R. and Naftolin, F. (1983) Catechol estrogens and estrogen receptors. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York, pp. 151-165.
135. Martucci, C. and Fishman J. (1979) Impact of continuously administered catechol estrogens on uterine growth and LH secretion. Endocrinology, 105, 1288-1292.
136. Fishman, J. (1981) Biological action of catecholestrogens. J. Endocr., 85, 59P-65P.
137. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M. and Knuppen, R. (1993) Catecholestrogens are MCF-7 cell estrogen agonists. J. Steroid Biochem. Mol. Biol., 46, 781-789.
138. Schutze, N., Vollmer, G. and Knuppen, R. (1994) Catecholestrogens are agonists of estrogen receptor-dependent gene expression in MCF-7 cells. J. Steroid Biochem. Mol. Biol., 48, 453-461.
139. Schneider, J., Huh, M.M., Bradlow, H.L. and Fishman, J. (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259, 4840-4845.
140. Vandewalle, B. and Lefebvre, J. (1989) Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol. Cell. Endocrinol., 61, 239-246.
141. Yager, J.D. and Liehr, J.G. (1996) Molecular mechanisms of estrogen carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 36, 203-232.
142. Castracane, V.D. and Jordan, V.C. (1975) The effect of estrogen and progesterone on uterine prostaglandin biosynthesis in the ovariectomized rat. Biol. Reprod., 13, 587-596.
143. Castracane, V.D. and Jordan, V.C. (1976) Considerations into the mechanism of estrogen-stimulated uterine prostaglandin synthesis. Prostaglandins, 12, 243-251.
144. Kelly, R.W. and Abel, M.H. (1981) A comparison of the effects of 4-catechol oestrogens and 2-pyrogallol oestrogens on prostaglandin synthesis by the rat and human uterus. J. Steroid Biochem., 14, 787-791.
145. Pakrasi, P.L. and Dey, S.K. (1983) Catechol estrogens stimulate synthesis of prostaglandins in the preimplantation rabbit blastocyst and endometrium. Biol. Reprod., 29, 347-354.
146. Biswas, A., Chaudhury, A., Chattoraj, S.C. and Dale, S.L. (1991) Do catechol estrogens participate in the initiation of labor? Am. J. Obstet. Gyn., 165, 984-987.
147. Parvizi, N. and Ellendorff, F. (1983) Catechol estrogens in the brain: neuroendocrine integration. J. Steroid Biochem., 19, 615-618.
148. Braun, T. (1990) Inhibition of the soluble form of testis adenylate cyclase by catechol estrogens and other catechols. Proc. Soc. Exp. Biol. Med., 194, 58-63.
149. Fishman, J. and Tulchinsky, D. (1980) Suppression of prolactin secretion in normal young women by 2-hydroxyestrone. Science, 210, 73-74.
150. Linton, E.A., White, N., de Tineo, O.L. and Jeffcoate, S.L. (1981) 2-Hydroxyestradiol inhibits prolactin release from the superfused rat pituitary gland. J. Endocrinol., 90, 315-322.
151. Paden, C.M., McEwen, B.S., Fishman, J., Snyder, L. and DeGroff, V. (1982) Comparison by estrogens for catecholamine receptor binding in vitro. J. Neurochem., 39, 512-520.
152. Schaeffer, J. and Hsueh, A. (1979) 2-Hydroxyestradiol interactions with dopamine receptor binding in rat anterior pituitary. J. Biol. Chem., 254, 5606-5608.
153. Schaefer, J., Stevens, S., Smith, R. and Hsueh, A. (1980) Binding of 2-hydroxyestradiol to rat anterior pituitary cell membrane. J. Biol. Chem., 255, 9838-9843.
154. Pietras, R.J. and Szego, C.M. (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature, 265, 69-72.
155. Bression, D., Michard, M., Le Dafniet, M., Pagesy, P. and Peillon, F. (1986) Evidence for a specific estradiol binding site on the pituitary membrane. Endocrinology, 119, 1048-1051.
156. Watson, C.S., Pappas, T.C. and Gametchu, B. (1995) The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ. Hlth Perspect., 103 (Suppl. 7), 41-50.
157. Silberzahn, P., Almahbobi, G., Dehennin, L. and Merouane, A. (1985) Estrogen metabolites in equine ovarian follicles: gas chromatographic-mass spectrometric determinations in relation to follicular ultrastructure and progestin content. J. Steroid Biochem., 22, 501-505.
158. Spicer, L.J. and Hammond, J.M. (1989) Regulation of ovarian function by catecholestrogens: current concepts. J. Steroid Biochem., 33, 489-501.
159. Liehr, J.G., Ulubelen, A.A. and Strobel, H.W. (1986) Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem., 261, 16865-16870.
160. Liehr, J.G. and Roy, D. (1990) Free radical generation by redox cycling of estrogens. Free Radical Biol. Med., 8, 415-423.
161. Liehr, J.G. (1990) Genotoxic effects of estrogens. Mutat. Res., 238, 269-276.
162. Nutter, L.M., Ngo, E.O. and Abul-Hajj, Y.J. (1991) Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J. Biol. Chem., 266, 16380-16386.
163. Han, X. and Liehr, J.G. (1994) DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis, 15, 997-1000.
164. Han, X. and Liehr, J.G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis. Cancer Res., 54, 5515-5517.
165. Cavalieri, E.L., Stack, D.E., Devanesan, P.D., Todorovic, R., Dwiredy, I., Higginbotham, S., Johansson, S.L., Patil, K.D., Gross, M.L., Gooden, J.K., Ramanathan, R., Cerny, L. and Rogan, E.G. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl Acad. Sci. USA, 94, 10937-10942.
166. Hayashi, N., Hasegawa, K., Komine, A., Tanaka, Y., McLachlan, J.A., Barrett, J.C. and Tsutsui, T. (1996) Estrogen-induced cell transformation and DNA-adduct formation in cultured Syrian hamster embryo cells. Mol. Carcinogenesis, 16, 149-156.
167. Li, S.A., Purdy, R.H. and Li, J.J. (1989) Variations in catechol-O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Carcinogenesis, 10, 63-67.
168. Roy, D., Weisz, J. and Liehr, J.G. (1990) The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. Carcinogenesis, 11, 459-462.
169. Lipsett, M.B., Merriam, G.R., Kono, S., Brandon, D.D., Pfeiffer, D.G. and Loriaux, D.L. (1983) Metabolic clearance of catechol estrogens. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York, pp. 105-114
170. Martucci, C. and Fishman, J. (1976) Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)estratriene-3,15α,16α,17β-tetrol). Steroids, 27, 325-333.
171. Barnea, E.R., MacLusky, N.J. and Naftolin, F. (1983) Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids, 41, 643.
172. Franks, S., MacLusky, N.J. and Naftolin, F. (1982) Comparative pharmacology of oestrogens and catecholestrogens: actions on the immature uterus in vivo and in vitro. J. Endocrinol., 94, 91-98.
173. 14C in surviving uterine segments by hydroxylated estradiols. Nature, 176, 127-128.
174. Hoversland, R.C., Dey, S.K. and Johnson, D.C. (1982) Catechol estradiol induced implantation in the mouse. Life Sci., 30, 1801-1804.
175. Kantor, B.S., Dey, S.K. and Johnson, D.C. (1985) Catecholoestrogen induced initiation of implantation in the delayed implanting rat. Acta Endocr., 109, 418-422.
176. Dey, S.K., Davis, D.L., Hersey, R.M., Weisz, J., Johnson, D.C. and Pakrasi, P.L. (1984) Physiological aspects of blastocyst uterine interaction. J. Biosci., 6 (Suppl.), 23-31.
177. Liehr, J.G. (1994) Mechanism of metabolic activation and inactivation of catechol estrogens: a basis of genotoxicity. Polycyclic Aromatic Compounds, 6, 229-239.
178. Cavalieri, E.L. (1994) Minisymposium on endogenous carcinogens: the catechol estrogen pathway. Polycyclic Aromatic Compounds, 6, 223-228.
179. Li, J.J., Gonzalez, S., Banerjee, S.K. and Li, S.A. (1993) Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ. Hlth Perspect., 101 (Suppl. 5), 259-264.
180. Li, J.J., Li, S.A., Oberley, T.D. and Parsons, J.A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: Relation to hormonal activity and cell proliferation. Cancer Res., 55, 4347-4351.
181. Li, J.J. and Li, S.A. (1995) Estrogen carcinogenesis in the hamster kidney: a hormone-driven multi-step process. In Huff, J. Boyd, J. and Barrett, J.C. (eds) Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. Wiley-Liss Inc., Philadelphia, pp. 247-259.
182. El-Bayoumy, K., Ji, B.-Y., Upadhyaya, P., Chae, Y.-H., Kurtzke., C., Rivenson, A., Reddy, B.S., Amin, S. and Hecht, S.S. (1996) Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in the rat mammary gland. Cancer Res., 56, 1970-1973.
183. Newbold, R.R., Bullock, B.C. and MacLachlan, J.A. (1990) Uterine adenocarcinoma in mice following developmental treatment with estrogen. Cancer Res., 50, 7677-7681.
184. Wiklund, J., Wertz, N. and Gorski, J. (1981) Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: correlation with pituitary tumor susceptibility. Endocrinology, 111, 1140-1149.
185. Zhu, B.T. and Liehr, J.G. (1993) Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamines: Implications for the mechanism of estrogen-induced carcinogenesis. Arch. Biochem. Biophys., 304, 248-256.
186. Castagnetta, L.A., Granata, O.M., Arcuri, F.P., Polito, L.M., Rosati, F. and Cartoni, G.P. (1992) Gas chromatography/mass spectrometry of catechol estrogens. Steroids, 57, 437-443.
187. Savas, Ü., Christou, M. and Jefcoate, C.R. (1993) Mouse endometrium stromal cells express a polycyclic aromatic hydrocarbon-inducible cytochrome P450 in mouse embryo fibroblasts (P450EF). Carcinogenesis, 14, 2013-2018.
188. Savas, Ü., Bhattacharyya, K.K., Christou, M., Alexander, D.L. and Jefcoate, C.R. (1994) Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem., 269, 14905-14911.
189. Hakkola, J., Pasanen, M., Pelkonen, O., et al. (1997) Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligand in human placenta and cultured cells. Carcinogenesis, 18, 391-397.
190. Shimada, T., Hayes, C.L., Yamazaki, H., Amin, S., Hecht, S.S., Guengerich, F.P. and Sutter, T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56, 2979-2984.
191. Brake, P.B., Christsou, M., Savas, Ü., Bhattacharyya, K., Alexander, D., Larsen, M. and Jefcoate, R. (1995) Selective expression and hormonal regulation of cytochrome P450 1B1 in mammary cells. Proc. Am. Ass. Cancer Res., 36, 257.
192. Bjeldanes, L.F., Kim, J.-Y., Grose, K.R., Bartholomew, J.C. and Bradfield, C.A. (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA, 88, 9543-9547.
193. 14 by mouse liver microsomes. J. Am. Chem. Soc., 79, 1004-1005.
194. Huggins, C. and Jensen, E.V. (1955) The depression of estrone-induced uterine growth by phenolic estrogens with oxygenated functions at positions 6 or 16: the impeded estrogens. J. Exp. Med., 102, 335-346.
195. Müller, R.E. and Wotiz, H.H. (1977) Post-coital contraceptive activity and estrogen receptor binding affinity of phenolic steroids. Endocrinology, 100, 513-519.
196. Takagi, H., Komatsu, K.-I. and Yoshizuwa, I. (1991) Synthesis and mechanism of hydrolysis of estrogen 6-sulfates: model compounds for demonstrating the carcinogenesis of estrogen. Steroids, 56, 173-179.
197. Phillips, D.H., Miller, J.A., Miller, E.C. and Adams, B. (1981) Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole. Cancer Res., 41, 176-186.
198. Watabe, T., Ishizuka, T., Isobe, M. and Ozawa, N. (1982) A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science, 215, 403-405.
199. Bonerg, E.W., Miller, E.C., Miller, J.A., Poland, A. and Liem, A. (1983) Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver. Cancer Res., 43, 5163-5173.
200. Laskin, A.I., Grabowich, P., Junta, B., de Lisle Meyers, C. and Fried, J. (1964) Microbial hydroxylation of estrone and estradiol in the 6β-, 7α, and 15α-positions. J. Org. Chem., 29, 1333-1336.
201. Knuppen, R., Haupt, M. and Breuer, H. (1965) Formation of 15α-hydroxyestradiol-17β and 1α-hydroxyestrone by human adrenal tissue. J. Endocrinol., 33, 529-530.
202. Younglai, E.V. and Solomon, S. (1968) Formation of estra-1,3,5(10)-triene-3,15α,16α, 17β-tetrol (estetrol) and estra-1,3,5(10)-triene-3,15α,17β-triol from neutral precursors. J. Clin. Endocrinol. Metab., 28, 1611-1617.
203. Cantineau, R., Kremers, P., De Graeve, J., Gielen, J.E. and Lambotte, R. (1985) 15- and 16-Hydroxylations of androgens and estrogens in the human fetal liver: a critical step in estetrol biosynthesis. J. Steroid Biochem., 22, 195-201.
204. 3H]17β-oestradiol in rats: male-specific 15α- and male-selective 16α-hydroxylation and female-selective catechol formation. J. Steroid Biochem. Mol. Biol., 42, 65-76.
205. Adlercreutz, H. and Martin, F. (1976) Oestrogens in human pregnancy faeces. Acta Endocrinol., 83, 410-419.
206. Schwers, J., Eriksson, G. and Diczfalusy, E. (1965) Metabolism of oestrone and oestradiol in the human foeto-placental unit at midpregnancy. Acta Endocrinol., 49, 65-82.
207. Gurpide, E., Schwers, J., Welch, M.T., Vande Wiele, R.L. and Lieberman, S. (1966) Fetal and maternal metabolism of estradiol during pregnancy. Clin. Endocrinol. Metab., 26, 1355-1365.
208. Schwers, J., Gurpide, E., Vande Wiele, R.L. and Lieberman, S. (1967) Urinary metabolites of estradiol and estriol administered intraamniotically. J. Clin. Endocrinol. Metab., 27, 1403-1408.
209. 3H by the previable human fetus at midterm. Acta Endocrinol., 63, 39-49.
210. Fishman, J., Schut, H. and Solomon, S. (1972) Metabolism, production and excretion rates of 15α-hydroxyestriol in late pregnancy. J. Clin. Endocrinol. Metab., 35, 339-344.
211. Tulchinsky, D., Frigoletto, F.D., Jr., Ryan, K.J. and Fishman, J. (1975) Plasma estetrol as an index of fetal well-being. J. Clin. Endocrinol. Metab., 40, 560-567.
212. Kundu, N. and Grant, M. (1976) Radioimmunoassay of 15α-hydroxyestriol (estetrol) in pregnancy serum. Steroids, 27, 785-796.
213. Notation, A.D. and Tagatz, G.E. (1977) Unconjugated estriol and 15α-hydroxyestriol in complicated pregnancies. Am. J. Obstet. Gynecol., 128, 747-756.
214. Taylor, N.F. and Schackleton, C.H.L. (1978) 15α-Hydroxyestriol and other polar oestrogens in pregnancy monitoring - a review. Ann. Clin. Biochem., 15, 1-11.
215. Zucconi, G., Lisboa, B.P., Simonitsch, E., Roth, L., Hagen, A.A. and Diczfalusy, E. (1967) Isolation of 15-hydroxy-oestriol from pregnancy urine and from the urine of newborn infants. Acta Endocrinol., 56, 413-423.
216. Klopper, A., Jandial, V. and Wilson, G. (1975) Plasma steroid assay in the assessment of fetoplacental function. J. Steroid Biochem., 6, 651-656.
217. Kunda, N. Wachs, M., Iverson, G. and Petersen, L.P. (1981) Comparison of serum unconjugated estriol and estetrol in normal and complicated pregnancies. Obstet. Gynec., 58, 276-281.
218. Chakraborty, C., Davis, D.L. and Dey, S.K. (1990) Estradiol-15α-hydroxylation: A new avenue of estrogen metabolism in peri-implantation pig blastocysts. J. Steroid Biochem., 35, 209-218.
219. Fishman, J. and Martucci, C. (1978) Differential biological activity of estradiol metabolism. Pediatrics, 62, 1128-1133.
220. Blume, N., Xu, Z.J., Arvind, P. and Leonard, J. (1996) Identification of a novel CYP2D gene expressed in the mammary gland and its potential role in the 16α-hydroxylation of estrogens. The American Endocrine Society Annual Meeting, Abstract No. P2-806.
221. Fishman, J. and Martucci, C.P. (1980) Biological properties of 16α-hydroxyestrone: implications in estrogen physiology and pathophysiology. J. Clin. Endocrinol. Metab., 51, 611-615.
222. Swaneck, G.E. and Fishman, J. (1988) Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl Acad. Sci. USA, 85, 7831-7835.
223. Hsu, C.-J., Kirkman, B.R. and Fishman, J. (1991) Differential expression of oncogenes c-fos, c-myc and neu/Her-2 induced by estradiol and 16α-hydroxyestrone in human cancer cell line. 73rd Annual Endocrine Society Meeting, Washington D.C., abstract # 586.
224. Miyairi, S., Ichikawa, T. and Nambara, T. (1991) Structure of the adduct of 16α-hydroxyestrone with a primary amine: evidence for the Heyns rearrangement of steroidal D-ring α-hydroxyamines. Steroids, 56, 361-366.
225. Bradlow, H.L., Herschcopf, R.J. and Fishman, J. (1986) Oestradiol 16α-hydroxylase: a risk marker for breast cancer. Cancer Surv., 5, 573-583.
226. Bradlow, H.L., Sepkovic, D.W., Telang, N.T. and Osborne, M.P. (1995) Indole-3-carbinol: A novel approach to breast cancer prevention. Ann. NY Acad. Sci., 768, 180-200.
227. Fishman, J., Osborne, M.P. and Telang, N.T. (1995) The role of estrogen in mammary carcinogenesis. Ann. NY Acad. Sci., 768, 91-100.
228. Fishman, J., Schneider, J., Hershcopf, R.J. and Bradlow, H.L. (1984) Increased estrogen 16α-hydroxylase activity in women with breast and endometrial cancer. J. Steroid. Biochem. Mol. Biol., 20, 1077-1081.
229. Bradlow, H.L. and Michnovicz, J.J. (1989) A new approach to the prevention of breast cancer. Proc. Roy. Soc. Edinburgh, 95B, 77-86.
230. Telang, N.T., Basu, A., Modak, M.J., Bradlow, H.L. and Osborne, M.P. (1988) Parallel enhancement of ras protooncogene expression and of estradiol-16α-hydroxylation in human mammary terminal duct-lobular units (TDLU) by a carcinogen. Breast Cancer Res. Treat., 12, 138.
231. Telang, N.T., Sato, A., Wong, G.Y., Osborne, M.P. and Bradlow, H.L. (1992) Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl Cancer Inst., 84, 634-638.
232. Suto, A., Bradlow, H.L., Wong, G.Y., Osborne, M.P. and Telang, N.T. (1993) Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res. Treat., 27, 193-202.
233. Bradlow, H.L., Hershcopf, R.J., Martucci, C.P. and Fishman, J. (1985) Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc. Natl Acad. Sci. USA, 82, 6295-6299.
234. Osborne, M.P., Telang, N.T., Kaur, S. and Bradlow, H.L. (1990) Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse. Steroids, 55, 114-119.
235. Jellinck, P.H., Michnovicz, J.J. and Bradlow, H.L. (1991) Influence of indole-3-caibinol on the hepatic microsomal formation of catechol estrogens. Steroids, 56, 446-450.
236. Jellinck, P.H., Forkert, P.G., Riddick, D.S., Okey, A.B., Michnovicz, J.J. and Bradlow, H.L. (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol., 45, 1129-1136.
237. Bradlow, H.L., Michnovicz, J.J., Telang, N.T. and Osborne, M.P. (1991) Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis, 12, 1571-1574.
238. Kojima, T., Tanaka, T. and Mori, H. (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res., 54, 1446-1449.
239. Davis, D.L., Bradlow, H.L., Wolff, M., Woodruff, T., Hoel, D.G. and Anton-Culver, H. (1993) Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Hlth Perspect., 101, 372-377.
240. Davis, D.L. and Bradlow, H.L. (1995) Can environmental estrogens cause breast cancer? Scientific American, 273, 167-172.
241. Bradlow, H.L., Davis, D.L., Lin, G., Sepkovic, D. and Tiwari, R. (1995) Effects of pesticides on the ratio of 16α/2-hydroxyestrone: A biological marker of breast cancer risk. Environ. Hlth Perspect., 103 (Suppl. 7), 147-150.
242. Sepkovic, D.W., Bradlow, H.L., Michnovicz, J., Murtezani, S., Levy, I. and Osborne, M.P. (1994) Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthaflavone: a comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods. Steroids, 59, 318-323.
243. Fishman, J. (1966) Stereochemistry of enolization of 17-keto steroids. J. Org. Chem., 31, 520-523.
244. Lemon, H.M., Heidel, J.W. and Rodriguez-Sierra, J.F. (1992) Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer, 69, 457-465.
245. Adlercreutz, H., Gorbach, S.L., Goldin, B.R., Woods, M.N., Dwyer, J.T. and Hämäläinen, E. (1994) Estrogen metabolism and excretion in Oriental and Caucasian women. J. Natl Cancer Inst., 86, 1076-1082.
246. Adlercreutz, H., Gorbach, S.L., Goldin, B.R., Woods, M.N., Dwyer, J.T., Höckerstedt, K., Wähälä, K., Hase, T., Hämäläinen, E. and Fotsis, T. (1994) Diet and urinary estrogen profile in various populations. A preliminary report. Polycyclic Aromatic Compounds, 6, 261-273.
247. Merrill, R.C. (1958) Estriol: a review. Physiol. Rev., 38, 463-480.
248. Fotsis, T. (1987) The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-II. Fractionation and quantitation of the main groups of estrogen conjugates. J. Steroid Biochem., 28, 215-226.
249. MacMahon, B., Cole, P., Lin, T.M., Lowe, C.R., Mirra, A.P., Ravnihar, B., Salber, E.J., Valaoras, V.G. and Yuasa, S. (1970) Age at first birth and breast cancer risk. Bull. Wld Hlth Org., 43, 209-221.
250. Yuan, J.-M., Yu, M.C., Ross, R.K., Gao, Y.T. and Henderson, B.E. (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res., 48, 1949-1953.
251. Henderson, B.E., Pike, M.C., Bernstein, L. and Ross, R.K. (1996) Breast cancer. In Schottenfeld, D. and Fraumeni, J.F., Jr (eds) Cancer Epidemiology and Prevention, 2nd edn. Oxford University Press, New York, Oxford, pp. 1022-1039.
252. Yang, N.N., Venugopalan, M., Hardikar, S. and Glasebrook, A. (1996) Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science, 273, 1222-1225.
253. Simpkins, J.W., Singh, M. and Bishop, J. (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging, 15, s195-s197.
254. Brenner, D.E., Kukull, W.A., Stergachis, A., van Belle, G., Bowen, J.D., McCormick, W.C., Teri, L. and Larson, E.B. (1994) Post-menopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol., 140, 262-267.
255. Barrett-Connor, E. and Kritz-Silverstein, D. (1993) Estrogen replacement therapy and cognitive function in older women. JAMA, 269, 2637-2641.
256. Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H. and Mayeux, R. (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429-432.
257. Naftolin, F., Leranth, C., Perez, J. and Garcia-Seyura, L.M. (1993) Estrogen induces synaptic plasticity in adult primate neuron. Neuroendocrinology, 57, 935-939.
258. Kuntzman, R., Jacobson, M., Schneidman, K. and Conney, A.H. (1964) Similarities between oxidative drug-metabolizing enzymes and steroid hydroxylases in liver microsomes. J. Pharmacol. Exp. Ther., 146, 280-285.
259. Conney, A.H. (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev., 19, 317-366.
260. Conney, A.H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res., 42, 4875-4917.
261. Guengerich, F.P. (1989) Polymorphism of cytochrome P-450 in humans. TIPS, 10, 107-109.
262. Kagimoto, M., Heim, M., Kagimoto, K., Zeugin, T. and Meyer, U.A. (1990) Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. J. Biol. Chem., 265, 17209-17214.
263. Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M.-L., Sjöqvist, F. and Ingelman-Sundberg, M. (1993) Inherited amplification of an active gene in the cytochrome P-450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc. Natl Acad. Sci. USA, 90, 11825-11829.
264. De Morais, S.M.F., Wilkinson, G.R., Blaisdell, J., Nakamura, K., Meyer, U.A. and Goldstein, J.A. (1994) Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in humans. J. Biol. Chem., 269, 15419-15422.
265. Gonzalez, F.J. and Gelboin, H.V. (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev., 26, 165-183.
266. Guengerich, F.P. (1995) Human cytochrome P450 enzymes. In Ortiz de Montellano, P.R. (ed.) Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York and London, 2nd edn. pp. 473-535.
267. Gonzalez, F.J. (1995) Genetic polymorphism and cancer susceptibility: fourteenth Sapporo cancer seminar. Cancer Res., 55, 710-715.
268. Welch, R.M., Levin, W. and Conney, A.H. (1967) Insecticide inhibition and stimulation of steroid hydroxylases in rat liver. J. Pharmacol. Exp. Ther., 155, 167-173.
269. Levin, W., Welch, R.M. and Conney, A.H. (1968) Effect of phenobarbital and other drugs on the metabolism and uterotropic action of estradiol-17β and estrone. J. Pharmacol. Exp. Ther., 159, 362-371.
270. Levin, W., Welch, R.M. and Conney, A.H. (1968) Decreased uterotropic potency of oral contraceptives in rats pretreated with phenobarbital. Endocrinology, 83, 149-156.
271. Welch, R.M., Levin, W., Kuntzman, R., Jacobson, M. and Conney, A.H. (1971) Effect of halogenated hydrocarbon insecticides on the metabolism and uterotropic action of estrogens in rats and mice. Toxicol. Appl. Pharmacol., 19, 234-246.
272. Kuntzman, R., Sansur, M. and Conney, A.H. (1965) Effect of drugs and insecticides on the anesthetic action of steroids. Endocrinology, 77, 952-954.
273. Conney, A.H., Jacobson, M., Levin, W., Schneidman, K. and Kuntzman, R. (1966) Decreased central depression effect of progesterone and other steroids in rats pretreated with drugs and insecticides. J. Pharmacol. Exp. Ther., 154, 310-318.
274. Levin, W., Welch, R.M. and Conney, A.H. (1969) Inhibitory effect of phenobarbital or chlordane pretreatment on the androgen-induced increase in seminal vesicle weight in the rat. Steroids, 13, 155-161.
275. Levin, W., Welch, R.M. and Conney, A.H. (1974) Increased liver microsomal androgen metabolism by phenobarbital: correlation with decreased androgen action on the seminal vesicles of the rat. J. Pharmacol. Exp. Ther., 188, 287-292.
276. Levin, W., Welch, R.M. and Conney, A.H. (1970) Effect of carbon tetrachloride and other inhibitors of drug metabolism on the metabolism and action of estradiol-17β and estrone in the rat. J. Pharmacol. Exp. Ther., 173, 247-255.
277. Michnovicz, J.J., Hershcopf, R.J., Naganuma, H., Bradlow, H.L. and Fishman, J. (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N. Eng. J. Med., 315, 1305-1309.
278. Michnovicz, J.J., Naganuma, H., Hershcopf, R.J., Bradlow, H.L. and Fishman, J. (1988) Increased urinary catechol estrogen excretion in female smokers. Steroids, 52, 69-83.
279. MacMahon, B., Trichopoulos, D., Cole, P. and Brown, J. (1982) Cigarette smoking and urinary estrogens. N. Engl. J. Med., 307, 1062-1065.
280. Jensen, J., Christiansen, C. and Rodbro, P. (1985) Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N. Engl. J. Med., 313, 973-975.
281. Friedman, A.J., Ravnikar, V.A. and Barbieri, R.L. (1987) Serum steroid hormone profiles in post-menopausal smokers and nonsmokers. Fertil. Steril., 47, 398-401.
282. Baron, J.A. (1984) Smoking and estrogen-related disease. Am. J. Epidemiol., 119, 9-22.
283. Jensen, J. and Christiansen, C. (1988) Effect of cigarette smoking on serum lipoproteins and bone mineral content during post-menopausal hormone replacement therapy. Am. J. Obstet. Gynecol., 159, 820-825.
284. Baron, J.A., Vecchia, C.L. and Levi, F. (1990) The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet. Gynecol., 162, 502-514.
285. Lesko, S.M., Rosenberg, L., Kaufman, D.W., et al. (1985) Cigarette smoking and the risk of endometrial cancer. N. Engl. J. Med., 313, 593-596.
286. Dent, C.E., Richens, A., Rowe, D.J.F. and Stamp, T.C.B. (1970) Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br. Med. J., 4, 69-72.
287. Hunter, J., Maxwell, J.D., Stewart, D.A., Parsons, V. and Williams, R. (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br. Med. J., 4, 202-204.
288. Hahn, T.J. and Halstead, L.R. (1983) Sequential changes in mineral metabolism and serum vitamin D metabolite concentrations produced by phenobarbital administration in the rat. Calcified Tissue Int., 35, 376-382.
289. Michnovicz, J.J. and Bradlow, H.L. (1991) Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr. Cancer, 16, 59-66.
290. Bradlow, H.L., Michnovicz, J.J., Wong, G.Y., Halper, M.P., Miller, D. and Osborne, M.P. (1994) Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol. Biomarkers Prevent., 3, 591-595.
291. Welch, R.M., Levin, W. and Conney A.H. (1968) Stimulatory effect of phenobarbital on the metabolism in vivo of estradiol-17β and estrone in the rat. J. Pharmacol. Exp. Ther., 160, 171-178.
292. Romkes, M. and Safe, S. (1988) Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in female rat uterus. Toxicol. Appl. Pharmacol., 92, 368-380.
293. Umbreit, T.H., Hesse, E.J., Macdonald, G.J. and Gallo, M.A. (1988) Effects of TCDD-estradiol interactions in three strains of mice. Toxicol. Lett., 40, 1-9.
294. DeVito, M.J., Thomas, T., Martin, E., Umbreit, T.H. and Gallo, M.A. (1992) Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue specific regulation of estrogen receptor in CD-1 mice. Toxicol. Appl. Pharmacol., 113, 284-292.
295. Gierthy, J.F., Lincoln, D.W., Gillespie, M.B., Seeger, J.I., Martinez, H.L., Dickerman, H.W. and Kumar, S.A. (1987) Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res., 47, 6198-6203.
296. Gierthy, J.F., Bennett, J.A., Bradley, L.M. and Cutler, D.S. (1993) Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res., 53, 3149-3153.
297. Kociba, R.J., Keyes, D.G., Beyer, J.E., et al. (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl. Pharmacol, 46, 279-303.
298. Williamson, D.G. (1979) The biochemistry of the 17-hydroxysteroid dehydrogenases. In Hobkirk, R. (ed.) Steroid Biochemistry, vol I. CRC Press, Boca Raton, FL, pp. 83-110.
299. Karavolas, H.J., Bacdecker, M.L. and Engel, L.L. (1970) Human placental 17β-estradiol dehydrogenase. V. Purification and partial characterization of the diphosphopyridine nucleotide (triphosphonucleotide) linked enzyme. J. Biol. Chem., 245, 4948-4952.
300. Blomquist, C.H., Lindemann, N.J. and Hakanson, E.Y. (1987) Steroid modulation of 17β-hydroxysteroid oxidoreductase activities in human placental villi in vitro. J. Clin. Endocrinol. Metab., 65, 647-652.
301. Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H.F., Couet, J., Leblanc, G. and Labrie, F. (1990) Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol. Endocrinol., 4, 268-275.
302. Pittaway, D.E., Andersen, R.N., Coleman, S.A. Jr., Givens, J.R. and Wiser, W.L. (1983) Human ovarian 17β-hydroxysteroid oxidoreductase activity. A comparison of normal and polycystic ovarian tissues. J. Clin. Endocrinol. Metab., 56, 715-719.
303. Martel, C., Rhéaume, E., Takahashi, M., Trudel, C., Couët, J., Luu-The, V., Simard, J. and Labrie, F. (1992) Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and in human tissues. J. Steroid Biochem. Mol. Biol., 41, 597-603.
304. Bleau, G., Roberts, K.D. and Chapdelaine, A. (1974) The in vitro and in vivo uptake and metabolism of steroid in human adipose tissue. J. Clin. Endocrinol. Metab., 39, 236-246.
305. Weisntein, G.D., Frost, P. and Hsia, S.L. (1968) In vitro interconversion of estrone and 17β-estradiol in human skin and vaginal mucosa. J. Invest. Dermat., 5, 4-10.
306. Tseng, L., Stolee, A. and Gurpide, E. (1972) Quantitative studies on the uptake and metabolism of estrogens and progesterone by human endometrium. Endocrinology, 90, 390-404.
307. Bonney, R.C., Reed, M.J., Davidson, K., Beranek, P.A. and James, V.H.T. (1983) The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin. Endocrinol., 19, 727-739.
308. 3H-oestradiol by normal breast and breast tumour tissue in post-menopausal women. Int. J. Cancer, 38, 193-196.
309. Vermeulen, A., Deslypere, J.P., Pavidaens, R., Leclevq, G., Roy, F. and Henson, J.C. (1986) Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in post-menopausal women. Eur. J. Cancer Clin. Oncol., 32, 515-522.
310. Poutanen, M., Isomaa, V., Kainulainen, K. and Vihko, R. (1990) Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line. Int. J. Cancer, 46, 897-901.
311. Adams, E.F., Rafferty, B. and White, M.C. (1991) Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity in MCF-7 cells: possible paracrine regulation of breast oestradiol levels. Int. J. Cancer, 49, 118-121.
312. Couture, P., Thériault, C., Simard, J. and Labrie, F. (1993) Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology, 132, 179-185.
313. Duncan, L.J., Coldham, N.G. and Reed, M.J. (1994) The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J. Steroid Biochem. Mol. Biol., 49, 63-68.
314. Jacobson, G.M. and Hochberg, R.B. (1968) 17β-Hydroxysteroid dehydrogenase from human red blood cells. J Biol. Chem., 243, 2985-2994.
315. Kaufrnann, M., Carstensen, J., Husen, B. and Adamski, J. (1995) The tissue distribution of porcine 17β-estradiol dehydrogenase and its induction by progesterone. J. Steroid Biochem. Mol. Biol., 55, 535-539.
316. Tseng, L. and Gurpide, E. (1972) Changes in the in vitro metabolism of estradiol during the menstrual cycle. Am. J. Obstet. Gynecol., 114, 1002-1008.
317. Tseng, L. and Gurpide, E. (1975) Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology, 97, 825-833.
318. Casey, M.L., MacDonald, P.C. and Andersson, S. (1994) 17β-Hydroxysteroid dehydrogenase type 2: Chromosome assignment and progestin regulation of gene expression in human endometrium. J. Clin. Invest., 94, 2135-2141.
319. King, R.J.B., Townsend, P.T. and Whitehead, M.I. (1981) The role of estradiol dehydrogenase in mediating progestin effects on endometrium from post-menopausal women receiving estrogens and progestins. J. Steroid Biochem., 14, 235-238.
320. Luu-The, V., Zhang, Y., Poirier, D. and Labrie, F. (1995) Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition. J. Steroid Biochem. Mol. Biol., 55, 581-587.
321. Singh, A. and Reed, M.J. (1991) Insulin-like growth factor I and insulin-like growth factor II stimualte oestradiol 17β-hydroxysteroid dehydrogenase activity in breast cancer cells. J. Endocrinol., 129, R5-R8.
322. Singh, A., Blench, I., Morris, H.R., Savoy, L.-A. and Reed, M.J. (1992) Synergistic interaction of growth factors and albumin in regulating estradiol synthesis in breast cancer cells. Mol. Cell. Endocrinol., 85, 165-173.
323. Peltoketo, H., Isomaa, V., Maentausta, O. and Vihko, R. (1988) Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett., 239, 73-77.
324. Luu-The, V., Labrie, C., Zhao, H.F, Couët, J., Lachance, Y., Simard, J., LeBlanc, G., Gôté, J., Bérubé, G., Gagné, R. and Labrie, F. (1989) Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′ termini in human placenta. Mol. Endocrinol., 3, 1301-1309.
325. Wu, L., Einstein, M., Geissler, W.M., Chan, H.K., Elliston, K.O. and Andersson, S. (1993) Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J. Biol. Chem., 268, 12964-12969.
326. Geissler, W.M., Davis, D.L., Wu, L., Bradshaw, K.D., Patel, S., Mendonca, B.B., Elliston, K.O., Wilson, J.D., Russell, D.W. and Andersson, S. (1994) Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genet., 7, 34-39.
327. Leenders, F., Adamski, J., Husen, B., Thole, H.H. and Jungblut, P.W. (1994) Molecular cloning and amino acid sequence of the porcine 17 beta-estradiol dehydrogenase. Eur. J. Biochem., 222, 221-227.
328. Labrie, F. (1991) Intracrinology. Mol. Cell. Endocrinol., 78, C113-C118.
329. Ryan, K.J. (1959) Biological aromatization of steroids. J. Biol. Chem., 234, 268-272.
330. Simpson, E.R., Mahendroo, M.S., Means, G.D., Kilgore, M.W., Hinshelwood, M.M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C.R., Michael, M.D., Mendelson, C.R. and Bulun, S.E. (1994) Aromatase cytochrome P450, the isozyme responsible for estrogen metabolism. Endocr. Rev., 15, 342-355.
331. McNatty, K.P., Baird, D.T., Bolton, A., Chambers, P., Corker, C.S. and MacLean, H. (1976) Conversion of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J. Endocrinol., 71, 77-85.
332. Tan, L. and Muto, N. (1986) Purification and reconstitution properties of human placental aromatase. A cytochrome P-450-type monooxygenase. Eur. J. Biochem., 156, 243-250.
333. Naftolin, F., Ryan, K.J., Davis, I.J., Reddy, V.V. Flores, F., Petro, Z. and Huhn, M. (1975) The formation of estrogen by central neuroendocrine tissues. Recent Prog. Horm. Res., 31, 295-315.
334. Selmanoff, M.K., Brodkin, L.D., Weiner, L.D. and Siiteri, P.K. (1977) Aromatization and 5α-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology, 101, 841-848.
335. Naftolin, F. and MacLusky, N.J. (1982) Aromatase in the central nervous system. Cancer Res., 42 (Suppl.), 3274s-3276s.
336. Schindler, A.E., Ebert, A. and Frederick, E. (1972) Conversion of androstenedione to estrone by human fat tissue. J. Clin. Endocrinol. Metab., 35, 627-630.
337. Nimrod, A. and Ryan, K.J. (1975) Aromatization of androgens by human abdominal and breast fat tissue. J. Clin. Endocrinol. Metab., 40, 367-379.
338. Smuk, M. and Schwers, J. (1977) Aromatization of androstenedione by human adult liver in vitro. J. Clin. Endocrinol. Metab., 45, 1009-1012.
339. Schweikert, H.U., Milewick, L. and Wilson, J.D. (1976) Aromatization of androstenedione by cultured human fibroblasts. J. Clin. Endocrinol. Metab., 43, 785-795.
340. Berkovitz, G.D., Fujimoto, M., Brown, T.R., Brodie, A.M. and Migeon, C.J. (1984) Aromatase activity in cultured human genital skin fibroblasts. J. Clin. Endocrinol. Metab., 59, 665-671.
341. Miller, W.R. and Forrest, A.P.M. (1974) Oestradiol synthesis by human breast carcinoma. Lancet, 2, 866-868.
342. Lipton, A., Santner, S.J., Santen, R.J., Harvey, H.A., Feil, P.D., White-Hershey, D., Bartholomew, M.J. and Antle, C.E. (1987) Aromatase activity in primary and metastatic human breast cancer. Cancer, 59, 779-782.
343. Esteban, J.M., Warsi, Z., Haniu, M., Hall, P., Shively, J.E. and Chen, S. (1992) Detection of intratumoral aromatase in breast carcinoma: an immunohistochemical study with clinicopathologic correlation. Am. J. Pathol., 140, 337-343.
344. O'Neill, J.S., Elton, R.A. and Miller, W.R. (1988) Aromatase activity in adipose tissue from breast quadrants: a link with tumor site. Br. Med. J., 296, 741-743.
345. Santen, R.J., Martel, J., Hoagland, M., Naftolin, F., Rao, L., Harada, N., Hafer, L., Zaino, R. and Santner, S.J. (1994) Stromal spindle cells contain aromatase in human breast tumors. J. Clin. Endocrinol. Metab., 79, 627-632.
346. Zumoff, B. (1982) Relationship of obesity to blood estrogens. Cancer Res., 42, 3289s-3294s.
347. Siiteri, P.K., Williams, J.E. and Takaki, N.K. (1976) Steroid abnormalities in endometrial and breast carcinoma: a unifying hypothesis. J. Steroid Biochem., 7, 897-903.
348. Siiteri, P.K. (1981) Extraglandular estrogen formation and serum binding of estradiol: relationship to cancer. J. Endocrinol., 89 (Suppl.), 119P-129P.
349. Siiteri, P.K. (1982) Review of studies on estrogen biosynthesis in the human. Cancer Res., 42 (suppl.), 3269s-3273s.
350. Santen, R.J., Martel, J., Hoagland, M., Naftolin, F., Roa, L., Harada, N., Hafer, L., Zaino, R. and Santener, S.T. (1994) Stromal spindle cell distribution of aromatase in human breast tumors. J. Clin. Endocrinol. Metab., 79, 627-632.
351. Miller, W.R. (1989) Aromatase inhibitors in the treatment of advanced breast cancer. Cancer Treat. Rev., 16, 83-93.
352. Demers, L.M. (1994) Effects of fadrozole (CGS 16949) and letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients. Breast Cancer Res. Treat., 30, 95-102.
353. Yue, W., Wang, J., Savinov, A. and Brodie, A. (1995) Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model. Cancer Res., 55, 3073-3077.
354. Means, G.D., Mahendroo, M.S., Corbin, C.J., Mathis, M.J., Powell, F.E., Mendelson, C.R. and Simpson, E.R. (1989) Scructural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem., 264, 19385-19391.
355. Toda, K., Terashima, M., Kawamoto, T., et al. (1990) Structural and functional characterization of human aromatase P450 gene. Eur. J. Biochem., 193, 559-565.
356. Kilgore, M.W., Means, G.D., Mendelson, C.R. and Simpson, E.R. (1992) Alternative promotion of aromatase P-450 expression in the human placenta. Mol Cell. Endocrinol., 83, R9-R16.
357. Harada, N., Utsumi, T. and Takagi, Y. (1993) Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc. Natl Acad. Sci. USA. 90, 11312-11316.
358. Simpson, E.R., Michael, M.D., Agarwal, V.R., Hinshelwood, M.M., Bulun, S.E. and Zhao, Y. (1997) Expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB J., 11, 29-36.
359. Harada, N., Utsumi, T. and Takagi, Y. (1995) Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics, 5, S59-S64.
360. Mahendroo, M.S., Mendelson, C.R. and Simpson, E.R. (1993) Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P-450 gene expression in human adipose tissue. J. Biol. Chem., 268, 19463-19470.
361. Lipton, A., Santner, S.J., Santen, R.J., Harvey, H.A., Feil, P.D., White-Hersey, D., Bartholomew, M.J. and Antle, C.E. (1987) Aromatase activity in primary and metastatic human breast cancer. Cancer, 59, 779-782.
362. Longcope, C. (1996) Dehydroepiandrosterone metabolism. J. Endocrinol., 150, S125-S127.
363. Dao, T.L., Hayes, C. and Libby, P.R. (1974) Steroid sulfatase activities in human breast tumors. Proc. Soc. Exp. Biol. Med., 146, 381-384.
364. Vignon, F., Terqui, M., Westley, B., Derocq, D. and Rochefort, H. (1980) Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology, 106, 1079-1086.
365. Carlstrom, K., von Uexkull, A.-K., Einhorn, N., Fredricsson, B., Lunell, N.-O. and Sundelin, P. (1983) Metabolism of estrone sulfate in human endometrium. Acta Obstet. Gynecol. Scand., 62, 519-524.
366. Tseng, L., Mazella, J., Lee, L.Y. and Stone, M.L. (1983) Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma. J. Steroid Biochem., 19, 1413-1417.
367. Santner, S.J., Feil, P.D. and Santen, R.J. (1984) In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J. Clin. Endocrinol. Metab., 59, 29-33.
368. MacIndoe, J.H., Woods, G., Jeffries, L. and Hinkhouse, M. (1988) The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology. 123, 1281-1287.
369. Carlstrom, K., Bergqvist, A. and Ljungberg, O. (1988) Metabolism of estrone sulfate in endometriotic tissue and in uterine endometrium in proliferative and secretory phase. Fertil. Steril., 49, 229-233.
370. Santner, S.J., Leszczynski, D., Wright, C., Manni, A., Feil, P.D. and Santen, R.J. (1986) Estrone sulfate: a potential source of estradiol in human breast cancer tissues. Breast Cancer Res. Treat., 7, 35-44.
371. Millington, D.S. (1975) Determination of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography. J. Steroid Biochem., 6, 239-243.
372. Trévoux, R., De Brux, J., Castanier, M., Nahoul, K., Soule, J.-P. and Scholler, R. (1986) Endometrium and plasma hormone profile in the perimenopause and post-menopause. Maturitas, 8, 309-326.
373. 14-16 sulfate in women. Am. J. Obstet. Gynecol., 80, 889-326.
374. Ruder, H.J., Loriaux, L. and Lipsett, M.B. (1972) Estrone sulfate: Production rate and metabolism in man. J. Clin. Invest., 51, 1020-1033.
375. Santen, R.J., Leszczynski, D., Tilson-Mallet, N., Feil, P.D., Wright, C., Manni, A. and Santner, S.J. (1986) Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann. N. Y. Acad. Sci., 464, 126-137.
376. Milewich, L., Garcia, R.L. and Gerrity, L.W. (1984) Steroid sulfatase and 17β-hydroxysteroid oxidoreductase activities in mouse tissues. J. Steroid Biochem., 21, 529-538.
377. Zhu, B.T. and Fu, J.-H. (1997) Uterine estrogen sulfatase plays a more important role than hepatic sulfatase in determining the sensitivity of the uterus to estrone-3-sulfate. Endocrine, 7, 191-198.
378. Pasqualini, J.R., Gelly, C., Nguyen, B.-L. and Vella, C. (1989) Importance of estrogen sulfates in breast cancer. J. Steroid Biochem., 34, 155-163.
379. Santner, S.J., Levin, M.C. and Santen, R.J. (1990) Estrone sulfate stimulates growth of nitrosomethylurea-induced breast carcinoma in vivo in the rat. Int. J. Cancer. 46, 73-78.
380. Zhu, B.T, Evaristus, E.N., Antoniak, S.K., Sarabia, S.F., Ricci, M.J. and Liehr, J.G. (1996) Metabolic deglucuronidation and demethylation of estrogen conjugates as a source of parent estrogens and catechol estrogen metabolites in Syrian hamster kidney, a target organ of estrogen-induced tumorigenesis. Toxicol. Appl Pharmacol., 136, 186-193.
381. Walaszek, Z., Hanusek, M., Sherman, U. and Adams, A.K. (1990) Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland. Cancer Lett., 49, 51-57.
382. Walaszek, Z., Hanausek-Walaszek, M. and Webb, T.E. (1984) Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4: 6,3-dilactone, an in vivo β-glucuronidase inhibitor. Carcinogenesis, 5, 767-772.
383. Walaszek, Z., Hanausek-Walaszek, M., Minton, J.P. and Webb, T.E. (1986) Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Carcinogenesis, 7, 1463-1466.
384. Walaszek, Z. (1990) Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett., 54, 1-8.
385. Watanabe, K. and Yoshizawa, I. (1987) Tissue distribution of estradiol 17-sulfate 2- and 4-hydoxylation enzymes in the rat. J. Pharmacobio-Dyn., 10, 302-308.
386. Ingelman-Sundberg, M., Rane, A. and Gustafasson, J.-A.̊ (1975) Properties of hydroxylase systems in the human fetal liver active on free and sulfoconjugated steroids. Biochemistry. 14, 429-437.
387. Duncan, L., Purohit, A., Howarth, N.M., Potter, B.V.L. and Reed, M.J. (1993) Inhibition of estrogen sulfatase activity by estrone-3-methyl-thiophosphonate: A potential therapeutic agent in breast cancer. Cancer Res., 53, 298-303.
388. Howarth, N.M., Purohit, A., Reed, M.J. and Potter, B.V.L. (1994) Estrone sulfamates: Potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem., 37, 219-221.
389. Reed, M.J., Purohit, A., Woo, L.W.L. and Potter, B.V.L. (1996) The development of steroid sulfatase inhibitors. Endocr. Rel. Cancer, 3, 9-23.
390. Lamer, J.M., Maclusky, N.J. and Hochberg, R.B. (1985) The naturally occurring C-17 fatty acid esters of estradiol are long-acting estrogens. J. Steroid Biochem., 22, 407-413.
391. Vazquez-Alcantara, M.A., Menjivar, M., Garcia, G.A., Diaz-Zagoya, J.C. and Garza-Flores, J. (1989) Long-acting estrogenic responses of estradiol fatty acid esters. J. Steroid Biochem., 33, 1111-1118.
392. Janocko, L., Lamer, J.M. and Hochberg, R.B. (1984) The interaction of C-17 esters of estradiol with the estrogen receptor. Endocrinolgoy, 114, 1180-1186.
393. Axelrod, J. and Tomchick, R. (1958) Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem., 233, 702-705.
394. Guldberg, H.C. and Marsden, C.A. (1975) Catechol-O-methyltransferase: Pharmacological aspects and physiological role. Pharmacol. Rev., 27, 135-206.
395. Thakker, D.R. and Creveling, C.R. (1990) O-Methylation. In Mulder, G.J. (ed.) Conjugation Reactions in Drug Metabolism. Taylor & Francis Ltd, London, pp. 193-232.
396. Axelrod, J., Albers, W. and Clemente, C.D. (1959) Distribution of catechol-O-methyltransferase in the nervous system and other tissues. J. Neurochem., 5, 68-71.
397. Inoue, K., Tice, L.W. and Creveling, C.R. (1977) Immunocytochemical localization of catechol-O-methyltransferase. In Usdin, E, Weiner, N. and Youdim, M.B.H. (eds) Structure and Function of Monoamine Enzymes. Marcel Dekker, New York, pp. 835-859.
398. Amin, A.M., Creveling, C.R. and Lowe, M.C. (1983) Immunohistochemical localization of catechol methyltransferase in normal and cancerous breast tissues of mice and rats. J. Natl Cancer Inst., 70, 337-342.
399. Assicot, M., Contesso, G. and Bohuon, C. (1977) Catechol-O-methyltransferase in human breast cancers. Eur. J. Cancer, 13, 961-966.
400. Bertocci, B., Miggiano, V., Da Prada, M., Dembic, Z., Lahm, H.W. and Malherbe, P. (1991) Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc. Natl Acad. Sci. USA, 88, 1416-1420.
401. Kraychy, S. and Gallagher, T.F. (1957) 2-Methoxyestrone, a new metabolite of estradiol-17β in man. J. Biol. Chem., 229, 519-526.
402. Ball, P. Reu, G., Schwab, J. and Knuppen, R. (1979) Radioimmunoassay of 2-hydroxyestrone and 2-methoxyestrone in human urine. Steroids, 33, 563-576.
403. Ball, P. and Knuppen, R. (1990) Formation, metabolism, and physiologic importance of catecholestrogens. Am. J. Obstet. Gynecol, 163, 2163-2170.
404. Dunn, J.F. (1983) Transport of estrogens in human plasma. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York. pp. 167-176.
405. Merriam, G.R., MacLusky, N.J., Pickard, M.K. and Naftolin, F. (1980) Comparative properties of the catechol estrogens. I: Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors. Steroids, 369, 1-11.
406. Jellinck, P.H. and Newcombe, A.M. (1980) Effect of catechol estrogens and estriol on the induction of uterine peroxidase. J. Steroid Biochem., 13, 681-683.
407. Gordon, S, Cantrall, E.W., Cekleniak, W.P., Albers, H.J., Mauer, S., Stolar, S.M. and Bernstein, S. (1964) Steroid and lipid metabolism. The hypocholesteremic effect of estrogen metabolites. Steroids, 4, 787-791.
408. Patt, V., Möllering, M. and Breuer, H. (1971) The effect of 2-or 4-substituted derivatives of oestrogens on blood lipids in rats. Arzneimittel-Forsch., 21, 308-310.
409. Ferreri, L.F. and Naito, H.K. (1978) Effect of estrogen on rat serum cholesterol concentrations: consideration of dose, type of estrogen, and treatment duration. Endocrinology, 102, 1621-1627.
410. Martucci, C. (1982) Induction of rat plasma renin substrate by 2-methoxyestrone. The Endocrine Society 64th Annual Meeting. Abstract No. 889.
411. Katayama, S. and Fishman, J. (1982) 2-Hydroxyestrone suppresses and 2-methoxyestrone augments the preovulatory prolactin surge in the cycling rat. Endocrinology, 110, 1448-1450.
412. Cushman, M., He, H.M., Katzenellenbogan, J.A., Lin, C.M. and Hamel, E. (1995) Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J. Med. Chem., 38, 2041-2049.
413. Zhu, B.T. and Liehr, J.G. (1994) Quercetin increases the seventy of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol., 125, 149-158.
414. Zhu, B.T. and Liehr, J.G. (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestadiol by quercetin: possible role in estradiol-induced tumorigenesis. J. Biol. Chem., 271, 1357-1363.
415. Riley, V. (1975) Mouse mammary tumors: alteration of incidence as apparent function of stress. Science, 189, 465-467.
416. Cooper, C.L. (ed.) (1988) Stress and Breast Cancer. John Wiley & Sons, Chichester.
417. Cooper, C.L., Cooper, R. and Faragher, E.B. (1989) Incidence and perception of psychosocial stress: the relationship with breast cancer. Psychol. Med., 19, 415-422.
418. Faragher, E.B. and Cooper, C.L. (1990) Type A stress prone behavior and breast cancer. Psychol. Med., 20, 663-670.
419. Forsen, A. (1991) Psychosocial stress as a risk for breast cancer. Psychother. Psychosom., 55, 176-185.
420. MacLusky, N.J., Naftolin, F., Krey, L.C. and Franks, S. (1981) The catechol estrogen. J. Steroid Biochem., 15, 111-124.
421. Levin, M., Weisz, J., Bui, Q.D. and Santen, R.J. (1987) Peroxidatic catecholestrogen production by human breast cancer tissue in vitro. J. Steroid Biochem., 28, 513-520.
422. Cohn, C.K., Dunner, D.L. and Axelrod, J. (1970) Reduced catechol-O-methyltransferase activity in red blood cells of women with primary effective disorder. Science, 170, 1323-1324.
423. Weinshilboum, R.M., Raymond, F.A., Elveback, L.R. and Weidman, W.H. (1974) Correlation of erythrocyte catechol-O-methyltransferase activity between siblings. Nature, 252, 490-491.
424. Weinshilboum, R.M. and Raymond, F.A. (1977) Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am. J. Hum. Genet., 29, 125-135.
425. Weinshilboum, R. (1989) Methyltransferase pharmacogenetics. Pharmacol. Ther., 43, 77-90.
426. Boudíková, B., Szumlanski, C., Maidak, B. and Weinshilboum, R. (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin. Pharmacol. Ther., 48, 381-389.
427. Schatz, F. and Hochberg, R.B. (1981) Lipoidal derivative of estradiol: The biosynthesis of a nonpolar estrogen metabolite. Endocrinology, 109, 697-703.
428. Mellon-Nussbaum, S.H., Ponticorvo, L., Schatz F. and Hochberg, R.B. (1982) Estradiol fatty acid esters: The isolation and identification of the lipoidal derivative of estradiol synthesized in the bovine uterus. J. Biol. Chem., 257, 5678-5684.
429. Abul-Hajj, Y.J. (1982) Formation of estradiol-17β fatty acyl 17-esters in mammary tumors. Steroids, 40, 149-155.
430. Adams, J,B., Hall, R.T. and Nott, S. (1986) Esterification-deesterification of estradiol by human mammary cancer cells in culture. J. Steroid Biochem., 24, 1159-1162.
431. Martyn, P., Smith, D.L. and Adams, J.B. (1987) Selective turnover of the essential fatty acid ester components of estradiol-17β lipoidal derivatives formed by human mammary cancer cells in culture. J. Steroid Biochem., 28, 393-398.
432. Hochberg, R.B., Zielinski, J.E., Larner, J.M. and Pahuja, S.L. (1991) Steroid esterification and hormone action. In Hochberg, R.B. and Naftolin, F. (eds) The New Biology of Steroid Hormones. Raven Press, New York, pp. 31-43.
433. Martyn, P., Smith, D.L. and Adams, J.B. (1988) Properties of fatty acyl-coenzyme A: estradiol-17β acyltransferase in bovine placenta microsomes. Mol. Cell. Endocrinol., 60, 7-13.
434. Pahuga, S.L., Zielinski, J.E., Giordano, G., McMurray, W.J. and Hochberg, R.B. (1991) The biosynthesis of D-ring fatty acid esters of estriol. J. Biol. Chem., 266, 7410-7416.
435. Katz, J., Finlay, T.H., Banerjee, S. and Levitz, M. (1987) An estrogen-dependent esterase activity in MCF-7 cells. J. Steroid Biochem., 26, 687-692.
436. Janocko, L. and Hochberg, R.B. (1983) Estradiol fatty acid esters occur naturally in human blood. Science, 222, 1334-1336.
437. Hershcopf, R.J., Bradlow,H .L., Fishman, J., Swaneck, G.E., Larner, J.M. and Hochberg, R.B. (1985) Metabolism of estradiol fatty acid esters in man. J. Clin. Endocrinol. Metab., 61, 1071-1075.
438. Larner, J.M., Shackleton, C.H.L., Roitman, E., Schwartz, P.E. and Hochberg, R.B. (1992) Measurement of estradiol-17-fatty acid esters in human tissues. Endocrinology, 75, 195-200.
439. Maclusky, N.J., Larner, J.M. and Hochberg, R.B. (1989) Actions of an estradiol-17-fatty acid ester in estrogen target tissues of the rat: Comparison with other C-17 metabolites and a pharmacological C-17 ester. Endocrinology, 124, 318-324.
440. Xu, S., Zhu, B.T. and Conney, A.H. (1997) Stimulatory effect of peroxisome proliferators on the formation of estradiol fatty acid esters by rat liver microsomes. Proc. Am. Ass. Cancer Res., 38, 451.
441. Fuqua, A., Fitzgerald, S.D., Chamness, G.C., Tandon, A.K., McDonnell, D.P., Nawaz, Z, O'Malley, B.W. and McGuire, W.L. (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51, 105-109.
442. Pfeffer, U., Fecarotta, E. and Vidali, G. (1995) Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and MCF-7 cells. Cancer Res., 55, 2158-2165.
443. Pink, J.J. Wu, S.Q., Wolf, D.M., Bilimoria, M.M. and Jordan, V.C. (1996) A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7. Nucleic Acids Res., 24, 962-969.
444. Grandien, K. (1996) Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol. Cell. Endocrinol., 116, 207-212.
445. Markaverich, B.M. and Clark, J.H. (1979) Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response. Endocrinology, 105, 1458-1462.
446. 3H]estradiol exchange. Endocrinology, 109, 62-69.
447. Xu, X. and Thomas, M.L. (1995) Biophasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity binding sites. Endocrine, 3, 661-665.
448. Markaverich, B.M., Gregory, R.R., Alejandro, M.A., Clark, J.H., Johnson, G.A. and Middleditch, B.S. (1988) Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear type II binding sites. J. Biol. Chem., 263, 7203-7210.
449. Laudet, V., Hänni, C., Coll, J., Catzeflis, F. and Stehelin, D. (1992) Evolution of the nuclear receptor gene superfamily. EMBO J., 11, 1003-1012.
450. Larsen, P.R. (1982) Thyroid-pituitary interaction. Feed back regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med., 306, 23-32.
451. Crantz, F.R., Silva, J.E. and Larson, P.R. (1982) An analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology, 110, 367-375.
452. Wilson, J.D. (1996) Role of dihydrotestosterone in androgen action. Prostate, 6 (Suppl.), 88-92.
453. Henry, H.L. (1992) Vitamin D hydroxylases. J. Cell. Biochem., 49, 4-9.
454. Conney, A.H. and Kappas, A. (1985) Interindividual differences in the metabolism of xenobiotics. In Huberman, E. and Barr, S.H. (eds) The Role of Chemicals and Radiation in the Etiology of Cancer. Raven Press, New York, pp. 147-166.
455. Meyer, U.A. (1994) Molecular genetics of human xenobiotic metabolizing cytochromes P450. Proceedings of the 10th International Symposium on Microsomes and Drug Oxidations, Toronto, Canada, pp. 2-4.
456. De Morais, S.M.F., Wilkinson, G.R., Blaisdell, J., Meyer, U.A., Nakamura, K. and Goldstein, J.A. (1994) Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol. Pharmacol., 46, 594-598.
457. Anderson, K.E., Kappas, A., Conney, A.H., Bradlow, H.L. and Fishman, J. (1984) The influence of dietary protein and carbohydrate on the principal oxidative biotransformation of estradiol in normal subjects. J. Clin. Endocrinol. Metab., 59, 103-107.
458. van Loon, J. and Weinshilboum, R. (1984) Human platelet phenol sulfotransferase: familial variations in the thermal stability of the TS form. Biochem. Genet., 22, 997-1014.
459. Weinshilboum, R. (1990) Sulfotransferase pharmacogenetics. Pharmacol. Ther., 45, 93-107.
460. Lea, O.A., Thorsen, T. and Kvinnsland, S. (1987) Extracellular proteins in breast tumor cytosol. Anticancer Res., 7, 113-118.
461. Søreide, J.A., Lea, O.A. and Kvinnsland, S. (1991) Cytosol albumin content in operable breast cancer. Acta Oncol., 30, 797-802.
462. Rao, G.S. (1981) Mode of entry of steroid and thyroid hormones into cells. Mol. Cell. Endocrinol., 21, 97-108.
463. Fishman, J., Cox, R.I. and Gallagher, T.F. (1960) 2-Hydroxyestrone: A new metabolite of estradiol in man. Arch. Biochem. Biophys., 90, 318-319.
464. Jellinck, P.H. and Lucieer, J. (1965) Sex differences in the metabolism of oestrogens by rat liver microsomes. J. Endocrinol., 32, 91-98.
465. King, R.J.B. (1961) Oestriol metabolism by rat- and rabbit-liver slices. Isolation of 2-methoxyoestriol and 2-hydroxyoestriol. Biochem. J., 79, 355-361.
466. Willians, J.G., Longcope, C. and Williams, K.I.H. (1974) 4-Hydroxyestrone: a new metabolite of estradiol from humans. Steroids, 24, 687-701.
467. Emons, G., Hoppen, H.-O., Ball, P. and Knuppen, R. (1980) 4-Hydroxyestrone, isolation and identification in human urine. Steroids, 36, 73-79.
468. Breuer, H., Knuppen, R. and Pangels, G. (1962) Configuration of a fourth Kober-chromogen from the urine of pregnant women. Biochim. Biophys. Acta, 65, 1-12.
469. Breuer, H., Knuppen, R. and Haupt, M. (1966) Metabolism of oestrone and estradiol-17β in human liver in vitro. Nature, 212, 76.
470. Zucconi, G. Lisboa, B.P., Simonitsch, E., Roth, L., Hagen, A.A. and Diczfalusy, E. (1967) Isolation of 15α-hydroxy-oestriol from pregnancy urine and from the urine of new born infants. Acta Endocrinol., 56, 413-423.
471. Hoppen, H.-O., Bohlig, H.-J., Werner, M. and Knuppen, R. (1976) Metabolism of oestrone and oestradiol in the isolated perfused rat liver. Hoppe-Seyler's Z. Physiol. Chem., 357, S67-S74.
472. Knuppen, R. and Breuer, H. (1962) Biogenesis of 11β-hydroxyoestrone and 16α-hydroxyoestrone by adrenal tissue. Biochim. Biophys. Acta, 58, 147-148.
473. Adlercreutz, H., Ervast, H.-S., Tenhunen, A. and Tikkanen, M.J. (1973) Gas chromatographic and mass spectrometric studies on oestrogens in bile: Part I. Pregnant women. Acta Endocrinol., 73, 543-554.
474. Loke, K.H. and Chong-Yong, G. (1968) 14α-Hydroxylation of oestrone by porcine adrenals. Steroids, 11, 863-875.
475. Knuppen, R., Haupt, O. and Breuer, H. (1967) 14α-Hydroxyestrone, a new estrogen metabolite. Biochem. J., 105, 971.
476. Adlercreutz, H. and Martin, F. (1976) Oestrogen in human pregnancy faeces. Acta Endocrinologica, 83, 410-419.
477. Knuppen, R., Haupt, M. and Breuer, H. (1965) Formation of 15α-hydroxyoestradiol-17β and 18-hydroxyoestrone by human adrenal tissue. J. Endocrinol., 33, 529-530.
478. Marriam, G.F., Watson, E.J.D. and Panattoni, M. (1957) The isolation of a ketonic dihydroxy Kober chromogen from the urine of pregnant women. Biochem. J., 65, 12-18.
479. Marrian, G.F., Loke, K.H., Watson, E.J.D. and Panattoni, M. (1957) 16α-Hydroxyoestrone in the urine of pregnant women. Biochem. J., 66, 60-65.
480. 14 to radioactive 16-ketoestradiol-17β in man. J. Biol. Chem., 222, 981-990.
481. Layne, D.S. and Marrian, G.F. (1958) Isolation of 16β-hydroxyoestrone from the urine of pregnant women. Nature, 182, 50-51.
482. Gallagher, T.F., Kraychy, S., Fishman, J., Brown, J.B. and Marrian, G.F. (1958) A comparison of methods for the analysis of estrone, estradiol, and estriol in extracts of human urine. J. Biol. Chem., 233, 1093-1096.
483. Doisy, E.A., Thayer, S.A., Levin, L. and Curtis, J.M. (1930) A new triatomic alcohol from the urine of pregnant women. Proc. Soc. Biol. Med., 28, 88-89.
484. 14-estrone in normal individuals. J. Clin. Invest., 38, 619-629.
485. Breuer, H., Knuppen, R. and Pangels, G. (1959) Stoffwechsel von 16-ketooestron in menschlichen geweben. Acta Endocrinol., 30, 247-258.
486. Marrian, G.F. (1930) Chemistry of estrin. IV. The chemical nature of crystalline preparation. Biochem. J., 24, 1021-1030.
487. Marrian, G.F. and Bauld, W.S. (1955) The isolation of 16-epiestriol from the urine of pregnant women. Biochem. J., 59, 136-141.
488. Adlercreutz, H., Diczfalusy, E. and Engström, L. (1960) Isolation and identification of bile estrogens in pregnant women. Endocrinology, 66, 80-88.
489. 14. Anal. Biochem., 2, 114-125.
490. Adlercreutz, H., Ervast, H.S., Tenhunen, A. and Tikkanen, M.J. (1973) Gas chromatographic and mass spectrometric studies on oestrogens in bile: Part I. Pregnant women. Acta Endocrinol., 73, 543-554.
491. Layne, D.S. and Marrian, G.F. (1958) The isolation of 16α-hydroxyestrone and 16-oxo-oestradiol-17β from the urine of pregnant women. Biochem. J., 70, 244-248.
492. Breuer, H. and Pangels, G. (1960) Isolierung von 17-epi-Östriol und 16,17-epi-Östriol aus dem Urin schwangerer Frauen. Hoppe-Seyler's Z. Physiol. Chem., 322, 177-183.
493. Heard, R.D.H., Bauld, W.S. and Hoffman, M.M. (1941) Steroids. V. α-Estradiol and progesterone metabolism. J. Biol. Chem., 141, 709-710.
494. Adlercreutz, H. and Luukkainen, T. (1965) Gas-chromatographic studies on oestrogens in the bile of pregnant women. Biochim. Biophys. Acta, 97, 134-141.
495. Loke, K.H., Marrian, G.F., Johnson, W.S., Meyer, W.L. and Cameron, D.D. (1958) Isolation and identification of 18-hydroxyoestrone from the urine of pregnant women. Biochim. Biophys. Acta, 28, 214.
496. Loke, K.H., Marrian, G.F. and Watson, W.J.D. (1959) The isolation of a sixth Kober chromogen from the urine of pregnant women and its identification as 18-hydroxyoestrone. Biochem. J., 71, 43-48.